Adrien Lemoine is the Chief Business Officer (CBO) at LifeArc.
He brings over 23 years of experience in the pharmaceutical and biotech sectors, with a strong track record in entrepreneurship, business development, R&D strategy, programme management, and financing.
Adrien’s career has been largely dedicated to the rare disease ecosystem, where he previously served as CEO and co-founder of Bloomsbury Genetic Therapies and Chief Business Officer at Orchard Therapeutics. In these roles, he led successful collaborations with academic institutions and biotech partners, contributing to programmes across discovery, preclinical, clinical, and commercial stages.
Adrien’s experience in the pharmaceutical industry involves leading strategy and operations for GSK’s Rare Diseases team and corporate development at AstraZeneca.
Adrien is also a trustee of Metabolic Support UK, a charity supporting people living with inherited metabolic conditions and their communities.
